Skip to main navigation Skip to search Skip to main content

Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial)

  • Jan H. Cornel
  • , Pierluigi Tricoci
  • , Yuliya Lokhnygina
  • , David J. Moliterno
  • , Lars Wallentin
  • , Paul W. Armstrong
  • , Philip E. Aylward
  • , Robert M. Clare
  • , Edmond Chen
  • , Sergio Leonardi
  • , Frans Van De Werf
  • , Harvey D. White
  • , Claes Held
  • , John Strony
  • , Kenneth W. Mahaffey
  • , Robert A. Harrington

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science